Daniel Rohle

2.8k total citations · 1 hit paper
5 papers, 1.7k citations indexed

About

Daniel Rohle is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Daniel Rohle has authored 5 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Genetics and 1 paper in Oncology. Recurrent topics in Daniel Rohle's work include Glioma Diagnosis and Treatment (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Nuclear Structure and Function (1 paper). Daniel Rohle is often cited by papers focused on Glioma Diagnosis and Treatment (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Nuclear Structure and Function (1 paper). Daniel Rohle collaborates with scholars based in United States, Switzerland and United Kingdom. Daniel Rohle's co-authors include Carl Campos, Ingo K. Mellinghoff, Craig B. Thompson, Patrick S. Ward, Olga A. Guryanova, Chao Lü, Emrullah Yilmaz, Timothy A. Chan, Logan A. Walsh and Armida W. M. Fabius and has published in prestigious journals such as Nature, Nature Communications and Cancer Research.

In The Last Decade

Daniel Rohle

5 papers receiving 1.6k citations

Hit Papers

IDH1 mutation is sufficient to establish the glioma hyper... 2012 2026 2016 2021 2012 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Rohle United States 4 1.0k 847 824 197 175 5 1.7k
Olivier Keunen Luxembourg 13 754 0.7× 744 0.9× 537 0.7× 107 0.5× 253 1.4× 23 1.5k
Christopher R. Edwards United States 5 1.3k 1.2× 707 0.8× 588 0.7× 121 0.6× 155 0.9× 7 1.8k
Dan Rohle United States 3 1.0k 1.0× 685 0.8× 527 0.6× 119 0.6× 153 0.9× 3 1.5k
Emrullah Yilmaz United States 12 986 1.0× 712 0.8× 768 0.9× 254 1.3× 327 1.9× 57 1.7k
Armida W. M. Fabius Netherlands 15 1.5k 1.5× 933 1.1× 1.1k 1.3× 305 1.5× 370 2.1× 24 2.5k
Timothy A. Chan United States 9 1.4k 1.4× 863 1.0× 964 1.2× 302 1.5× 357 2.0× 13 2.2k
Michael Blough Canada 17 596 0.6× 445 0.5× 582 0.7× 84 0.4× 231 1.3× 21 1.1k
Kenneth Aldape United States 13 1.2k 1.1× 686 0.8× 473 0.6× 347 1.8× 557 3.2× 32 1.9k
Jeremy Travins United States 13 947 0.9× 640 0.8× 346 0.4× 76 0.4× 194 1.1× 21 1.4k
Luca Persano Italy 26 1.1k 1.1× 676 0.8× 572 0.7× 142 0.7× 591 3.4× 55 2.0k

Countries citing papers authored by Daniel Rohle

Since Specialization
Citations

This map shows the geographic impact of Daniel Rohle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rohle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rohle more than expected).

Fields of papers citing papers by Daniel Rohle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rohle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rohle. The network helps show where Daniel Rohle may publish in the future.

Co-authorship network of co-authors of Daniel Rohle

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Rohle. A scholar is included among the top collaborators of Daniel Rohle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Rohle. Daniel Rohle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Gutiérrez, Nuria Martí, Luise Wolf, Stefka Tyanova, et al.. (2022). DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF. Life Science Alliance. 5(9). e202101235–e202101235. 8 indexed citations
2.
Hogg, Simon J., et al.. (2019). Abstract 4485: Enhancing antitumor immune responses with clinical BET bromodomain inhibitor RG6146. Cancer Research. 79(13_Supplement). 4485–4485. 1 indexed citations
3.
Oldrini, Barbara, Wan-Ying Hsieh, Hediye Erdjument‐Bromage, et al.. (2017). EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nature Communications. 8(1). 2035–2035. 24 indexed citations
4.
Venneti, Sriram, Mark Dunphy, Hanwen Zhang, et al.. (2015). Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Science Translational Medicine. 7(274). 274ra17–274ra17. 244 indexed citations
5.
Turcan, Şevin, Daniel Rohle, Anuj Goenka, et al.. (2012). IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 483(7390). 479–483. 1382 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026